Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD

Clinical trial NCT02096952 · COMPLETED

Trial details

NCT number: NCT02096952
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention-deficit/Hyperactivity Disorder Autism Spectrum Disorder

Start date: 2014-05-01
Primary completion: 2018-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.